Professor Janet Shipley
Professor Janet Shipley is Head of the Division of Molecular Pathology and leads the Sarcoma Molecular Pathology Team at the The Institute of Cancer Research, London.
Originally from Newcastle upon Tyne, Professor Shipley obtained her PhD from the University of London. She joined ICR following previous laboratory experience at the Paediatric Research Unit at Guy’s Hospital, the Genetics Division of Harvard Medical School, Boston US and the Imperial Cancer Research Fund (now the Crick).
She has been awarded Fellowship of the Royal College of Pathologists (FRCPath). She is a member of the National Cancer Research Institute (NCRI) Clinical Studies Young Onset Sarcoma Subgroup (YOSS), she chairs the Biological Committee for the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) and is Biology Lead in the current international trial for Frontline and Relapse Rhabdomyosarcoma patients (FaR-RMS).
Her research is focused on identifying molecular markers of high-risk in young onset sarcomas and understanding associated molecular mechanisms in order to derive novel treatments for these patients.